Foresight Analytics recently completed a ratings assessment of both the Trilogy Monthly Income Trust and the Trilogy Enhanced Income Fund, assigning both a ‘Very Strong’ investment rating.
This rating reaffirms the previous Foresight Analytics assessment from November 2023.
A ‘Very Strong’ rating indicates a very strong conviction that the fund can deliver a risk-adjusted return in line with its positive absolute return objective and that it is suitable for inclusion on most approved product lists.
In its assessment of the Trilogy Monthly Income Trust (the Trust), Foresight Analytics highlighted the experience of the Trilogy Funds team, and the ‘strong commitment to increasing the broader team’s expertise and developing very strong loan management systems.’
The assessment also noted that the Trust has never recorded a loss on a loan in default. Foresight stated that this “speaks well to the Manager’s lending processes, but it also speaks to several key risk mitigants of the Trust, specifically conservative LVRs tied with a very short-dated weighted average loan expiry, which markedly reduces general property-cycle risk.”
In its assessment of the Trilogy Enhanced Income Fund (the Fund), Foresight noted that “Trilogy has shown an impressive commitment to growth in the depth and breadth of resources in recent years in the areas of key importance to investors.”
The assessment also highlighted that the management team enhances its “… years of experience with multiple checks and balances to enable the Fund to achieve its objectives.’
Download the full reports below.
This article is issued by Trilogy Funds Management Limited ABN 59 080 383 679 AFSL 261425 (Trilogy Funds) as responsible entity for the Trilogy Monthly Income Trust ARSN 121 846 722 and Trilogy Enhanced Income Fund ARSN 614 682 469. Application for investment can only be made on the application form accompanying the Product Disclosure Statement (PDS) dated 3 May 2024 for the Trilogy Monthly Income Trust ARSN 121 846 722 and PDS dated 10 April 2024 for the Trilogy Enhanced Income Fund ARSN 614 682 469. The Trilogy Monthly Income Trust PDS and the Target Market Determination (TMD) dated 3 May 2024 and the Trilogy Enhanced Income Fund PDS and the TMD dated 10 April 2024 are available at www.trilogyfunds.com.au. The PDS contains full details of the terms and conditions of investment and should be read in full, particularly the risk section prior to lodging any application or making a further investment. All investments, including those with Trilogy Funds, involve risk which can lead to no or lower than expected returns, or a loss of part or all of your capital. Trilogy Funds is licensed to provide only general financial product advice about its products and therefore recommends you seek personal advice on the suitability of this investment to your objectives, financial situation and needs from a licensed financial adviser. Investments with Trilogy Funds are not bank deposits and are not government guaranteed. Past performance is not a reliable indicator of future performance.
